L. Fang

Metabolic Improvement Associated with Temporal Pattern of Weight Loss in Exenatide-Treated Patients With Type 2 Diabetes

D. Kendall, Jenny Han, R. Brodows, 2008 .

Population pharmacokinetic modeling of idelalisib, a novel PI3Kδ inhibitor, in healthy subjects and patients with hematologic malignancies

S. Ramanathan, Xiaoming Li, F. Jin, 2015, Cancer Chemotherapy and Pharmacology.

Bioequivalence of the Rilpivirine/Emtricitabine/Tenofovir AlafenamideSingle-Tablet Regimen

B. Kearney, H. Cao, E. Quirk, 2016 .

Bioequivalence of Two Co-formulations of Emtricitabine/TenofovirAlafenamide Fixed-Dose Combinations with 200/10 mg and 200/25 mg

B. Kearney, J. Koziara, M. Rhee, 2016 .